BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16150645)

  • 21. [Non-myeloablative allogeneic stem cell transplantation].
    Dalgaard J; Fløisand Y; Stenersen M; Egeland T; Brinch L
    Tidsskr Nor Laegeforen; 2007 Mar; 127(6):721-4. PubMed ID: 17363982
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A second prophylactic MHC-mismatched bone marrow transplantation protects against rat acute myeloid leukemia (BNML) without lethal graft-versus-host disease.
    Nestvold JM; Omdal BK; Dai KZ; Martens A; Benestad HB; Vaage JT; Rolstad B
    Transplantation; 2008 Jan; 85(1):102-11. PubMed ID: 18192919
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?
    Hirshfeld E; Weiss L; Kasir J; Zeira M; Slavin S; Shapira MY
    Bone Marrow Transplant; 2006 Sep; 38(5):359-64. PubMed ID: 16862165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Graft-versus-host disease confined solely to intestine after allogeneic peripheral blood stem cells transplantation in a patient with chronic myelogenous leukemia.
    Nomura K; Nakao M; Matsumoto Y; Taji S; Yoshida N; Mitsufuji S; Yokota S; Horiike S; Okanoue T; Taniwaki M
    Hematology; 2004 Apr; 9(2):131-3. PubMed ID: 15203868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
    Foss FM
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maintenance immunotherapy by repetitive low-dose donor lymphocytes infusions in a child with relapse state aml after allogeneic stem cell transplantation.
    Hartwig M; Weigel S; Bernig T; Bader P; Dölken R; Beck J
    Pediatr Hematol Oncol; 2007 Mar; 24(2):137-40. PubMed ID: 17454780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes simplex thymidine kinase (HStk) transgenic donor lymphocytes.
    Burt RK; Drobyski WR; Traynor AE; Link CJ
    Bone Marrow Transplant; 1999 Nov; 24(10):1043-51. PubMed ID: 10578153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence that donor intrinsic response to G-CSF is the best predictor of acute graft-vs-host disease following allogeneic peripheral blood stem cell transplantation.
    Dhédin N; Chamakhi I; Perreault C; Roy DC; Sauvageau G; Ducruet T; Busque L; Fish D; Bélanger R; Roy J
    Exp Hematol; 2006 Jan; 34(1):107-14. PubMed ID: 16413397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis.
    Owsianowski M; Gollnick H; Siegert W; Schwerdtfeger R; Orfanos CE
    Bone Marrow Transplant; 1994 Nov; 14(5):845-8. PubMed ID: 7889018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor lymphocyte infusion in the treatment of first hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia: a retrospective risk factors analysis and comparison with other strategies by the EBMT Acute Leukemia Working Party.
    Schmid C; Labopin M; Nagler A; Bornhäuser M; Finke J; Fassas A; Volin L; Gürman G; Maertens J; Bordigoni P; Holler E; Ehninger G; Polge E; Gorin NC; Kolb HJ; Rocha V;
    J Clin Oncol; 2007 Nov; 25(31):4938-45. PubMed ID: 17909197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD).
    Ayyildiz E; Arslan O; Topçuoğlu P; Arat M; Dalva K; Soydan EA; Tol M; Ilhan O
    Transfus Apher Sci; 2007 Feb; 36(1):79-85. PubMed ID: 17234454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crypt loss is a marker of clinical severity of acute gastrointestinal graft-versus-host disease.
    Melson J; Jakate S; Fung H; Arai S; Keshavarzian A
    Am J Hematol; 2007 Oct; 82(10):881-6. PubMed ID: 17570511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of donor lymphocyte infusions following mismatched stem cell transplantation.
    Or R; Hadar E; Bitan M; Resnick IB; Aker M; Ackerstein A; Samuel S; Tsirigotis P; Gesundheit B; Slavin S; Shapira MY
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1295-301. PubMed ID: 17162211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intensive extracorporeal photochemotherapy for severe acute hepatic graft-versus-host disease.
    Perotti C; Del Fante C; Viarengo G; Salvaneschi L
    Transfusion; 2004 Oct; 44(10):1531-2. PubMed ID: 15383028
    [No Abstract]   [Full Text] [Related]  

  • 38. Extracorporeal photopheresis in children with graft-versus-host disease.
    Chan KW
    J Clin Apher; 2006 Apr; 21(1):60-4. PubMed ID: 16619229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wireless capsule endoscopy for diagnosis of acute intestinal graft-versus-host disease.
    Neumann S; Schoppmeyer K; Lange T; Wiedmann M; Golsong J; Tannapfel A; Mossner J; Niederwieser D; Caca K
    Gastrointest Endosc; 2007 Mar; 65(3):403-9. PubMed ID: 17321239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of the extracorporeal photopheresis in the management of the graft-versus-host disease.
    Kaloyannidis P; Mallouri D
    Transfus Apher Sci; 2012 Apr; 46(2):211-9. PubMed ID: 22123355
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.